These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 20616418)

  • 61. Clarithromycin resistance of Helicobacter pylori has a major impact on the efficacy of the omeprazole-amoxicillin-clarithromycin therapy.
    Tankovic J; Lamarque D; Lascols C; Soussy CJ; Delchier JC
    Pathol Biol (Paris); 2001 Sep; 49(7):528-33. PubMed ID: 11642014
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Proton pump inhibitor or testing for Helicobacter pylori as the first step for patients presenting with dyspepsia? A cluster-randomized trial.
    Jarbol DE; Kragstrup J; Stovring H; Havelund T; Schaffalitzky de Muckadell OB
    Am J Gastroenterol; 2006 Jun; 101(6):1200-8. PubMed ID: 16771937
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Triple, standard quadruple and ampicillin-sulbactam-based quadruple therapies for H. pylori eradication: a comparative three-armed randomized clinical trial.
    Mirbagheri SA; Hasibi M; Abouzari M; Rashidi A
    World J Gastroenterol; 2006 Aug; 12(30):4888-91. PubMed ID: 16937475
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate.
    Okada M; Oki K; Shirotani T; Seo M; Okabe N; Maeda K; Nishimura H; Ohkuma K; Oda K
    J Gastroenterol; 1998 Oct; 33(5):640-5. PubMed ID: 9773927
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A randomized trial comparing seven-day ranitidine bismuth citrate and clarithromycin dual therapy to seven-day omeprazole, clarithromycin and amoxicillin triple therapy for the eradication of Helicobacter pylori.
    Veldhuyzen van Zanten S; Chiba N; Barkun A; Fallone C; Farley A; Cockeram A; Dallaire C; Simms L; Nicholls B
    Can J Gastroenterol; 2003 Sep; 17(9):533-8. PubMed ID: 14532926
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia?
    Spiller RC
    Eur J Gastroenterol Hepatol; 1999 Aug; 11 Suppl 2():S25-8; discussion S43-5. PubMed ID: 10503819
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.
    Talley NJ; Janssens J; Lauritsen K; Rácz I; Bolling-Sternevald E
    BMJ; 1999 Mar; 318(7187):833-7. PubMed ID: 10092259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice.
    Lee JM; Breslin NP; Hyde DK; Buckley MJ; O'Morain CA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):489-96. PubMed ID: 10215733
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Efficacy of Helicobacter pylori eradication in non-ulcer dyspepsia].
    González Carro P; Legaz Huidobro ML; Pérez Roldán F; Esteban López Jamar JM; Valenzuela Gámez JC; Ponte Tellechea A; Ruiz Carrillo F; Pedraza Martín C; Díaz de Rojas F; Sáez Bravo JM
    Med Clin (Barc); 2004 Jan; 122(3):87-91. PubMed ID: 14746696
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Therapeutic options after failed Helicobacter pylori eradication therapy.
    van der Hulst RW; Weel JF; van der Ende A; ten Kate FJ; Dankert J; Tytgat GN
    Am J Gastroenterol; 1996 Nov; 91(11):2333-7. PubMed ID: 8931413
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of rifaximin associated with standard triple therapy (omeprazole, clarithromycin and amoxicillin) for H. pylori eradication: A phase IV pilot clinical trial.
    Ramas M; Donday MG; McNicholl AG; Gisbert JP
    Gastroenterol Hepatol; 2017 Dec; 40(10):658-662. PubMed ID: 28780968
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Omeprazole plus clarithromycin and either tinidazole or tetracycline for Helicobacter pylori infection: a randomized prospective study.
    Zullo A; Rinaldi V; Pugliano F; Diana F; Attili AF
    Am J Gastroenterol; 1997 Nov; 92(11):2029-31. PubMed ID: 9362185
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
    Zullo A; Rinaldi V; Winn S; Meddi P; Lionetti R; Hassan C; Ripani C; Tomaselli G; Attili AF
    Aliment Pharmacol Ther; 2000 Jun; 14(6):715-8. PubMed ID: 10848654
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Role of omeprazole dosage and cytochrome P450 2C19 genotype in patients receiving omeprazole-amoxicillin dual therapy for Helicobacter pylori eradication.
    Yang JC; Wang HL; Chern HD; Shun CT; Lin BR; Lin CJ; Wang TH
    Pharmacotherapy; 2011 Mar; 31(3):227-38. PubMed ID: 21361732
    [TBL] [Abstract][Full Text] [Related]  

  • 75. One-week therapy with omeprazole, clarithromycin and metronidazole or ornidazole, followed by 3 weeks' treatment with omeprazole, eradicates Helicobacter pylori equally and heals duodenal ulcer.
    Tzivras M; Archimandritis A; Balatsos V; Delis V; Souyioultzis S; Skandalis N; Kanellopoulou E; Manika Z; Davaris P
    Eur J Gastroenterol Hepatol; 1997 Dec; 9(12):1185-9. PubMed ID: 9471024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia.
    Bruley Des Varannes S; Fléjou JF; Colin R; Zaïm M; Meunier A; Bidaut-Mazel C
    Aliment Pharmacol Ther; 2001 Aug; 15(8):1177-85. PubMed ID: 11472320
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Evaluation of the efficacy and tolerability of four different therapeutic regimens for the Helicobacter pylori eradication.
    Tursi A; Cammarota G; Montalto M; Papa A; Cuoco L; Veneto GM; Cannizzaro O; Fedeli G; Gasbarrini G
    Panminerva Med; 1996 Sep; 38(3):145-9. PubMed ID: 9009677
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Effect of Helicobacter pylori eradication on patients with functional dyspepsia].
    de Artaza Varasa T; Valle Muñoz J; Pérez-Grueso MJ; García Vela A; Martín Escobedo R; Rodríguez Merlo R; Cuena Boy R; Carrobles Jiménez JM
    Rev Esp Enferm Dig; 2008 Sep; 100(9):532-9. PubMed ID: 19025303
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Double-blind, multicenter, placebo-controlled evaluation of clarithromycin and omeprazole for Helicobacter pylori-associated duodenal ulcer.
    O'Morain C; Dettmer A; Rambow A; von Fritsch E; Fraser AG
    Helicobacter; 1996 Sep; 1(3):130-7. PubMed ID: 9398893
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Bismuth-based quadruple therapy using a single capsule of bismuth biskalcitrate, metronidazole, and tetracycline given with omeprazole versus omeprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in duodenal ulcer patients: a prospective, randomized, multicenter, North American trial.
    Laine L; Hunt R; El-Zimaity H; Nguyen B; Osato M; Spénard J
    Am J Gastroenterol; 2003 Mar; 98(3):562-7. PubMed ID: 12650788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.